News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CEO Pay Declines at Eli Lilly and Company (LLY), Rises at Bristol-Myers Squibb Company (BMY)


3/26/2013 9:57:45 AM

Eli Lilly & Co.'s (LLY) chief executive saw the value of his pay package decline by 11% for 2012, while the leader of rival drug maker Bristol-Myers Squibb Co. (BMY) received a 15% increase in total compensation. Both executives received generally positive performance reviews in their respective companies' proxy statements, but a smaller increase in the value of Lilly CEO John C. Lechleiter's pension benefits for 2012 accounted for the decline in his total compensation from 2011 levels. Bristol-Myers and Lilly both face similar challenges: Each has lost patent protection for top-selling drugs in recent years, triggering generic competition that hurt sales. But Bristol-Myers has generally had more success bringing new products to market to help soften the blow of the patent losses.

Read at Fox News
Read at News Release
Read at News Release
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES